NCT02074514 - Safety and Efficacy of Sofosbuvir Plus Ribavirin in Treatment-Naive Adults With Chronic Genotype 1 or 3 HCV Infection | Biotech Hunter

Enrollment

117

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

November 30, 2015

Conditions

Chronic HCV Infection

Interventions

DRUG

Sofosbuvir

400 mg tablet administered orally once daily

DRUG

RBV

200 mg tablets administered orally in a divided daily dose according to package insert weight-based dosing recommendations (\< 75 kg = 1000 mg and ≥ 75 kg = 1200 mg)

Trial Locations (13)

110029

New Delhi

110070

New Delhi

141001

Ludhiana

160012

Chandigarh

226014

Lucknow

302004

Jaipur

395002

Surat

400012

Mumbai

682040

Kochi

500 004

Hyderabad

122 001

Gurgaon

641 005

Coimbatore

700 020

Kolkata